Crispr Therapeutics shares owned by Stephens Consulting
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Stephens Consulting
from 13F filings
Historical chart of Stephens Consulting investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Stephens Consulting consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by Stephens Consulting
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $649 | 10 | 64.90 |
| 2025-06-30 | $487 | 10 | 48.70 |
| 2025-03-31 | $341 | 10 | 34.10 |
| 2024-12-31 | $394 | 10 | 39.40 |
| 2024-09-30 | $470 | 10 | 47.00 |